Health Care & Life Sciences » Biotechnology | ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
37,948.00
92,475.00
164,443.00
271,393.00
289,403.00
245,192
Depreciation, Depletion & Amortization
79.00
206.00
647.00
1,828.00
2,713.00
3,005
Other Funds
-
-
45.00
14,916.00
-
82,914
Funds from Operations
30,640.00
75,746.00
125,909.00
214,802.00
211,445.00
159,273
Changes in Working Capital
1,129.00
9,312.00
4,489.00
6,394.00
6,312.00
8,197
Net Operating Cash Flow
31,769.00
66,434.00
121,420.00
208,408.00
217,757.00
167,470
Capital Expenditures
618.00
180.00
2,141.00
9,506.00
812.00
Sale of Fixed Assets & Businesses
12.00
-
-
-
-
Purchase/Sale of Investments
125,498.00
87,093.00
149,336.00
252,418.00
93,285.00
Net Investing Cash Flow
126,104.00
87,273.00
147,195.00
261,924.00
92,473.00
Net Financing Cash Flow
111,682.00
203,851.00
14,502.00
533,812.00
31,188.00
Net Change in Cash
46,192.00
50,147.00
40,284.00
63,482.00
94,102.00
Free Cash Flow
32,387.00
66,614.00
123,561.00
209,914.00
218,569.00
Change in Capital Stock
111,682.00
203,851.00
14,547.00
518,896.00
31,188.00
Exchange Rate Effect
1.00
3.00
7.00
2.00
6.00

About ACADIA Pharmaceuticals

View Profile
Address
3611 Valley Centre Drive
San Diego California 92130
United States
Employees -
Website http://www.acadia-pharm.com
Updated 07/08/2019
ACADIA Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in central nervous system, or CNS, disorders. It operates through development and commercialization of innovative medicines segment. The company was founded by Mark R.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.